Professor Will Shu

Biomedical Engineering

Personal statement

Will Wenmiao Shu is the Hay Professor in Biomedical Engineering at the University of Strathclyde (Glasgow). He obtained his PhD at the University of Cambridge. Following his postdoctoral work at Cambridge University, he worked at Heriot-Watt University in Edinburgh's School of Engineering and Physical Sciences as a lecturer (2007-2012) and a Reader (2012-2016). His research interests cover a range of biomedical engineering topics including 3D biofabrication, biosensors, microsystems and their applications for regenerative medicine. He led the research to demonstrate the first bioprinting of human embryonic stem cells (h-ESCs) and human induced pluripotent stem cells (h-iPSCs), paving the way for their applications on animal-free drug testing and 3D printed organs. He was one of the founding members (and now an emeritus member) of Royal Society of Edinburgh’s Young Academy and held a visiting position at Stanford University. He is an editorial board member for IOP Biofabrication Journal and serves as a board director of the International Society for Biofabrication (ISBF).

Prizes and awards

Global Surgical Training Challenge Discovery Award: Recipient; 2021

More prizes and awards

Publications

Endothelialized microvessels fabricated by microfluidics facilitate osteogenic differentiation and promote bone repair: Wang Jiayuan, Wang Huan, Wang Yong, Liu Zhao, Li Zexi, Li Jiaying, Chen Qixin, Meng Qingchen, Shu Wenmiao Will, Wu Junxi, Xiao Can, Han Fengxuan, Li Bin; Acta Biomaterialia Vol 142, pp. 85-98 (2022); https://doi.org/10.1016/j.actbio.2022.01.055
A bioprinted heart-on-a-chip with human pluripotent stem cell-derived cardiomyocytes for drug evaluation: Faulkner-Jones Alan, Zamora Victor, Hortigon-Vinagre Maria P, Wang Wenxing, Ardron Marcus, Smith Godfrey L, Shu Wenmiao; Bioengineering Vol 9 (2022); https://doi.org/10.3390/bioengineering9010032
CD271 antibody-functionalized microspheres capable of selective recruitment of reparative endogenous stem cells for in situ bone regeneration: Sun Han, Guo Qianping, Shi Chen, McWilliam Ross H, Chen Jianquan, Zhu Caihong, Han Fengxuan, Zhou Pinghui, Yang Huilin, Liu Jinbo, Sun Xiaoliang, Meng Bin, Shu Wenmiao, Li Bin; Biomaterials Vol 280 (2021); https://doi.org/10.1016/j.biomaterials.2021.121243
3D bioprinting of complex, cell-laden alginate constructs: Tabriz Atabak Ghanizadeh, Cornelissen Dirk Jan, Shu Wenmiao; Computer-Aided Tissue Engineering (2021) (2021); https://doi.org/10.1007/978-1-0716-0611-7_12
Biofabrication for soft tissue and cartilage engineering: Turnbull Gareth, Clarke Jon, Picard Frédéric, Zhang Weidong, Riches Philip, Li Bin, Shu Wenmiao; Medical Engineering and Physics Vol 82, pp. 13-39 (2020); https://doi.org/10.1016/j.medengphy.2020.06.003
The bioprinting roadmap: Sun Wei, Starly Binil, Daly Andrew C, Burdick Jason A, Groll Jürgen, Skeldon Gregor, Shu Wenmiao, Sakai Yasuyuki, Shinohara Marie, Nishikawa Masaki, Jang Jinah, Cho Dong-Woo, Nie Minghao, Takeuchi Shoji, Ostrovidov Serge, Khademhosseini Ali, Kamm Roger D, Mironov Vladimir, Moroni Lorenzo, Ozbolat Ibrahim T; Biofabrication Vol 12 (2020); https://doi.org/10.1088/1758-5090/ab5158

More publications

Professional activities

Springer Nature (Publisher): Peer reviewer; 11/2016
2016 International Conference on Biofabrication: Chair; 31/10/2016
2016 International Conference on Biofabrication: Keynote/plenary speaker; 30/10/2016
13th Annual Norwegian Stem Cell Network Conference, Oslo September 15th, 2016: Keynote/plenary speaker; 15/9/2016
16th Annual Meeting of Tissue and Cell Engineering Society, UCL, London.: Keynote/plenary speaker; 4/7/2016
The British Transplantation Society Congress: Keynote/plenary speaker; 24/2/2016

More professional activities

Projects

Development of a vascularised bio-artificial human liver: Wu, Junxi (Principal Investigator) Shu, Will (Co-investigator); 01-Jan-2021 - 30-Jan-2024
Development an innovative vascularisation strategy for organ regeneration: Wu, Junxi (Principal Investigator) Shu, Will (Co-investigator); 01-Jan-2021 - 31-Jan-2023
Digital twin guided minimally invasive, intelligent and intuitive surgery (MI-3 Surgery): Shu, Will (Principal Investigator) Kazakidi, Asimina (Co-investigator) Luo, Xichun (Co-investigator); 01-Jan-2021 - 31-Jan-2022
Plug and play: an innovative bio-artificial artery for vascular reconstruction: Wu, Junxi (Principal Investigator) Shu, Will (Co-investigator); 01-Jan-2021 - 30-Jan-2024
Using graphene to generate tissues suitable for joint replacement components: Shu, Will (Principal Investigator) Gourlay, Terry (Co-investigator); 01-Jan-2021 - 30-Jan-2022
3D bioprinting-assisted construction of prevascularised bone tissue: Wu, Junxi (Principal Investigator) Shu, Will (Co-investigator); 30-Jan-2021 - 29-Jan-2023

More projects

Address

Biomedical Engineering
Wolfson Building

Location Map

View University of Strathclyde in a larger map